Stock Events

Stock Events

Lineage Cell Therapeutics (LCTX.TA) Q4 2024 Earnings

14NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-17.04

-11.37

-5.7

-0.03

Details

Expected EPS

-14.95352

Actual EPS

-7.47676

Surprise EPS

7.48

Surprise Percent

+50%

Description

Lineage Cell Therapeutics (LCTX.TA) has reported earnings of -7.47676 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.